ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK85.32

K85.32

Billable

Drug induced acute pancreatitis with infected necrosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K85.32 is a billable code used to indicate a diagnosis of drug induced acute pancreatitis with infected necrosis.

Key Diagnostic Point:

K85.32 refers to drug-induced acute pancreatitis with infected necrosis, a serious condition characterized by inflammation of the pancreas due to the adverse effects of certain medications. Clinically, patients may present with severe abdominal pain, nausea, vomiting, and fever. The anatomy involved primarily includes the pancreas, which is responsible for producing digestive enzymes and hormones. Infected necrosis indicates that the pancreatic tissue has died due to lack of blood supply and has become infected, often leading to systemic complications. Disease progression can vary; if untreated, it may lead to severe complications such as sepsis or multi-organ failure. Diagnostic considerations include imaging studies like CT scans to assess necrosis and laboratory tests to evaluate pancreatic enzyme levels. A thorough medication history is crucial to identify potential drug triggers, which may include certain antibiotics, diuretics, and immunosuppressants.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Diagnostic complexity: Requires comprehensive evaluation of clinical history and imaging.
  • Treatment complexity: Involves multidisciplinary management including surgery, antibiotics, and supportive care.
  • Documentation requirements: Detailed documentation of drug history, clinical findings, and treatment response is essential.
  • Coding specificity: Requires precise coding to differentiate from other types of pancreatitis.

Audit Risk Factors

  • Common coding errors: Misidentifying the cause of pancreatitis or failing to document the infected necrosis.
  • Documentation gaps: Incomplete medication history or lack of imaging results.
  • Billing challenges: Potential denials due to insufficient documentation or incorrect code selection.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Internal Medicine

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

K85.32 has significant clinical implications as it represents a severe form of pancreatitis that can lead to increased morbidity and mortality. The population health impact is notable, as drug-induced pancreatitis can result from commonly prescribed medications, highlighting the need for awareness among healthcare providers. Quality measures may include monitoring the incidence of drug-induced pancreatitis and ensuring appropriate management protocols are followed. Understanding epidemiological trends can help in identifying at-risk populations and improving healthcare utilization patterns.

ICD-9 vs ICD-10

K85.32 has significant clinical implications as it represents a severe form of pancreatitis that can lead to increased morbidity and mortality. The population health impact is notable, as drug-induced pancreatitis can result from commonly prescribed medications, highlighting the need for awareness among healthcare providers. Quality measures may include monitoring the incidence of drug-induced pancreatitis and ensuring appropriate management protocols are followed. Understanding epidemiological trends can help in identifying at-risk populations and improving healthcare utilization patterns.

Reimbursement & Billing Impact

Reimbursement may be affected by the completeness of the documentation, particularly regarding the identification of the drug causing the condition. Common denials may arise from insufficient evidence of the drug's role in the pancreatitis or lack of clarity in the documentation. Best practices include thorough documentation of the patient's clinical status and treatment response, as well as regular audits to ensure compliance with coding guidelines.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K85.32?

K85.32 specifically covers acute pancreatitis caused by drug exposure that has led to infected necrosis of the pancreatic tissue. This includes cases where the necrosis is confirmed via imaging and associated with clinical signs of infection.

When should K85.32 be used instead of related codes?

K85.32 should be used when there is clear evidence of drug-induced pancreatitis accompanied by infected necrosis. If there is no necrosis or infection, K85.31 or other related codes may be more appropriate.

What documentation supports K85.32?

Documentation should include a detailed medication history, imaging results confirming necrosis, laboratory tests indicating pancreatitis, and clinical notes describing the patient's symptoms and treatment plan.